Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4

PET Imaging of Integrin αVβ3 Expression

(2012) Ambros J. Beer et al.   Theranostics

18F-FDG PET/CT imaging in oncology

(2011) Ahmad Almuhaideb et al.   ANNALS OF SAUDI MEDICINE

Comparison Study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET Imaging of U87MG Tumors in Mice

(2011) Lixin Lang et al.   BIOCONJUGATE CHEMISTRY

Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products

(2011) O. Wahl et al.   CURRENT MEDICINAL CHEMISTRY

PET imaging of early response to the tyrosine kinase inhibitor ZD4190

(2011) Min Yang et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Angiogenesis in cancer

(2011) G. W. Prager et al.   Hamostaseologie

Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled  V 3-Integrin and  V 5-Integrin Imaging Agent

(2011) M. R. Battle et al.   JOURNAL OF NUCLEAR MEDICINE

Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4

(2011) Zhao-Hui Jin et al.   NUCLEAR MEDICINE AND BIOLOGY

Science to Practice: Pilot Study of FPPRGD2 for Imaging αvβ3Integrin—How Integral Are Integrins?

(2011) Peter L. Choyke   RADIOLOGY

Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels

(2011) Erik S. Mittra et al.   RADIOLOGY

RGD–cyclam conjugate: Synthesis and potential application for positron emission tomography

(2010) Mathieu Galibert et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors

(2010) Haruyasu Murakami et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors

(2010) Yutaka Ueda et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy

(2010) X. Sun et al.   JOURNAL OF NUCLEAR MEDICINE

Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

(2010) E. Vegt et al.   JOURNAL OF NUCLEAR MEDICINE

Noninvasive Imaging of  V 3 Function as a Predictor of the Antimigratory and Antiproliferative Effects of Dasatinib

(2009) R. A. Dumont et al.   CANCER RESEARCH

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours

(2009) Marleen Melis et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

(2009) Ingrid Dijkgraaf   Frontiers in Bioscience-Landmark

18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression

(2009) Shuanglong Liu et al.   MOLECULAR IMAGING AND BIOLOGY

Clustering and Internalization of Integrin αvβ3 With a Tetrameric RGD-synthetic Peptide

(2009) Sancey Lucie et al.   MOLECULAR THERAPY

Chemical and Biological Evaluations of an 111In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model

(2008) Mitra Ahmadi et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Use of a Novel Arg-Gly-Asp Radioligand, 18F-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy

(2008) M. S. Morrison et al.   JOURNAL OF NUCLEAR MEDICINE

Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients

(2008) L. M. Kenny et al.   JOURNAL OF NUCLEAR MEDICINE

Specific Expression of Endoglin (CD105) in Endothelial Cells of Intratumoral Blood and Lymphatic Vessels in Pancreatic Cancer

(2008) Hideyuki Yoshitomi et al.   PANCREAS